Registration
DB3, LLC (FKA THE DASCHLE GROUP) for VALISURE
Client
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI New | — |
| THOMAS DASCHLE New | Former United States Senator |
Defense DEF
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI New | — |
| THOMAS DASCHLE New | Former United States Senator |
Veterans VET
Issues related to drug quality; safety of the U.S. drug supply chain; H.R.3688, Recall Unsafe Drugs Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI New | — |
| THOMAS DASCHLE New | Former United States Senator |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.